Moderna Newsroom

Market Flips and Falls as Meta and MSTR Fall After Earnings | Wall Street Today

Kevin Travers16:55 ET

Is Moderna, Inc. (MRNA) The Worst Performing S&P 500 Stock In 2024?

Yahoo Finance13:53 ET

Market Climbs, SMCI Auditors Allege Mischief on Mischief Night | Live Stock

Kevin TraversOct 30 11:59 ET

WHO Expands Emergency Use List For Mpox Diagnostics, Adds Cepheid's Xpert Mpox PCR Test And Roche's Cobas MPXV Assay As PCR-Based Gold Standard Options

BenzingaOct 30 09:25 ET

Novocure Appoints Moderna's Exec Christoph Brackmann as CFO

Seeking AlphaOct 30 07:28 ET

GSK Dips as Lower Vaccine Sales Weigh on Q3 2024 Results

Seeking AlphaOct 30 06:43 ET

Moderna (MRNA) Exceeds Market Returns: Some Facts to Consider

Yahoo FinanceOct 29 17:50 ET

Nasdaq Hits Record High While Wed Earnings Are Mixed | Wall Street Today

Kevin TraversOct 29 17:25 ET

Tuesday Market Falls on Tough Earnings, With AMD and Alphabet Reporting Tonight | Live Stock

Kevin TraversOct 29 11:06 ET

Behind the Scenes of Moderna's Latest Options Trends

BenzingaOct 29 10:01 ET

Express News | BlackRock CEO Larry Fink, Blackstone CEO Stephen Schwarzman, Moderna CEO Stephane Bancel Attend Fii Conference in Riyadh

ReutersOct 29 02:55 ET

Slow Day to Start Busy Week | Wall Street Today

Kevin TraversOct 28 16:31 ET

Market Climbs as Investors Prepare for Biggest Earnings Week of the Year | Live Stock

Kevin TraversOct 28 11:40 ET

Express News | Moderna Shares Are Trading Higher After the Company Announced the Initiation of INTerpath-009 in Combination With KEYTRUDA as Adjuvant Treatment for Patients With Resectable Stage II, IIIA or IIIB Non-small Cell Lung Cancer Who Did Not Achieve a...

BenzingaOct 28 10:30 ET

Evercore Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $60

Moomoo NewsOct 28 08:31 ET · Ratings

Moderna Stock Price Target Slashed. It's About Vaccines. -- Barrons.com

Barron'sOct 28 07:53 ET · Ratings

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (MRNA-4157) in Combination With KEYTRUDA (Pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

BusinesswireOct 28 06:45 ET

Express News | Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (Mrna-4157) in Combination With Keytruda® (Pembrolizumab) After Neoadjuvant Keytruda and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (Nsclc)

ReutersOct 28 06:45 ET

It's Time to Get Your Covid and Flu Shots. Everything to Know About This Year's Vaccines. -- Barrons.com

Barron'sOct 26 12:29 ET

Weekly Buzz: Is Tesla a sign of earnings to come?

Kevin TraversOct 25 16:20 ET